Oragenics, Inc.

Oragenics, Inc.verified

OGEN

Price:

$0.6224

Market Cap:

$2.81M

Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2): NT-CoV2-1, an intranasal formulation, and Terra CoV-2, an intramuscular option. Beyond its infectious disease focus, Oragenics also has other experimental treatments under development, including LPT3-04, targeting weight loss, and SMaRT Replacement Therapy, a topical solution aimed at preventing dental cavities. Strategic alliances are also a part of its operations. This includes a licensing deal with Noachis Terra Inc. for patent...[Read more]

Industry

Biotechnology

IPO Date

2004-02-25

Stock Exchange

AMEX

Ticker

OGEN

The Enterprise Value as of June 2026 (TTM) for Oragenics, Inc. (OGEN) is -3242702.00

According to Oragenics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -3242702.00. This represents a change of -9.94% compared to the average of -3600788.51 of the last 4 quarters.

Oragenics, Inc. (OGEN) Historical Enterprise Value (quarterly & annually)

How has OGEN Enterprise Value performed in the past?

The mean historical Enterprise Value of Oragenics, Inc. over the last ten years is 506.72M. The current -3242702.00 Enterprise Value has changed -163.99% with respect to the historical average. Over the past ten years (40 quarters), OGEN's Enterprise Value was at its highest in in the March 2021 quarter at 2.77B. The Enterprise Value was at its lowest in in the September 2025 quarter at -10988482.21.

Quarterly (TTM)
Annual

Average

506.72M

Median

373.06M

Minimum

-2482956.08

Maximum

1.48B

Oragenics, Inc. (OGEN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Oragenics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 104.57%

Maximum Annual Enterprise Value = 1.48B

Minimum Annual Increase = -103.41%

Minimum Annual Enterprise Value = -2482956.08

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025-2482956.08-103.41%
202472.84M-80.67%
2023376.86M2.06%
2022369.26M-75.12%
20211.48B99.32%
2020744.73M15.26%
2019646.15M104.57%
2018315.85M-7.39%
2017341.07M-52.53%
2016718.50M-56.31%

Oragenics, Inc. (OGEN) Average Enterprise Value

How has OGEN Enterprise Value performed in the past?

The current Enterprise Value of Oragenics, Inc. (OGEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

149.07M

5-year avg

460.17M

10-year avg

506.72M

Oragenics, Inc. (OGEN) Enterprise Value vs. Peers

How is OGEN’s Enterprise Value compared to its peers?

Oragenics, Inc.’s Enterprise Value is less than AIM ImmunoTech Inc. (139.50K), less than KALA BIO, Inc. (55.91M), less than Ensysce Biosciences, Inc. (1.83M), less than Soligenix, Inc. (-1266892.00), less than Qualigen Therapeutics, Inc. (971.81K), less than Can-Fite BioPharma Ltd. (7.39B), less than Xenetic Biosciences, Inc. (-1303306.00), less than CNS Pharmaceuticals, Inc. (91.17K), greater than Kazia Therapeutics Limited (-36620371.31), greater than Titan Pharmaceuticals, Inc. (-66329351.00),

Build a custom stock screener for Oragenics, Inc. (OGEN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oragenics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oragenics, Inc. (OGEN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oragenics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Oragenics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Oragenics, Inc. (OGEN)?

What is the 3-year average Enterprise Value for Oragenics, Inc. (OGEN)?

What is the 5-year average Enterprise Value for Oragenics, Inc. (OGEN)?

How does the current Enterprise Value for Oragenics, Inc. (OGEN) compare to its historical average?